Introduction
With the successes to date in management of HIV in infants and children, including earlier diagnosis, early antiretroviral treatment (ART) initiation, and opportunistic infection (OI) prevention and treatment, rising numbers of children living with HIV are surviving into adolescence and adulthood. There are also significant numbers of youth with perinatal HIV infection who are newly diagnosed later in childhood and youth, particularly females, at high risk of acquiring HIV during the second decade of life [1, 2] . The clinical and psychosocial complexities of managing youth living with HIV (YLHIV) are increasingly being recognized, and disparities in their treatment and outcomes becoming more apparent as youth demonstrate greater nonadherence, attrition from care, morbidity, and mortality than their adult counterparts [3, 4] . For example, in the US an estimated 41 % of HIV-infected youth are aware of their status, 64 % of those enter care within 12 months, 54 % achieve viral suppression, and 57 % are not retained in care with only 6 % of adolescents remaining virally suppressed and in care [5] . Adherence rates in youth vary widely between reports from 25 to 99 %, with viral suppression rates ranging from 27 to 65 % [6] .
With an unprecedented number of YLHIV aging into adolescence and young adulthood worldwide, there is mounting concern about the possibility of these youth being lost in transition from pediatric to adult care settings and perhaps furthering the emerging disparities in outcomes. In resource-rich settings, there is high recognition of adolescent cognitive and developmental stages. Hence, adolescent medicine exists as a specialty with enhanced infrastructure targeted towards the care of youth. Despite this, transitioning YLHIV from pediatric to adult care remains one of the major challenges for YLHIV [7, 8] . In resource-limited settings (RLS), issues caused by a physical transfer from a pediatric to an adult care setting may not always be the primary concern since many areas share the same general HIV providers and even clinic space for pediatric, youth, and adult HIV populations. Furthermore, separate pediatric and adolescent clinics may not exist in many settings. In these cases, transitioning would emphasize independent adult care (navigating the healthcare system with less support) rather than a different clinical environment. Indeed, the identification of innovative ways to continue and maintain the delivery of quality HIV healthcare to all ages-from infancy through youth and into adulthood-remains more at the core of healthcare needs in low-and middle-income countries. Healthcare delivery approaches to meet the needs of HIV-infected individuals throughout a highly dynamic stage of life comprising adolescence and young adulthood may take precedence over discovering ways to transfer or move YLHIV from one healthcare setting to another.
Worldwide, there is a steadily increasing number of YLHIV, around 8 million in the next decade who may need to transition to an adult clinical setting, a reality that underscores the need to establish, define, understand, and solidify best practices for maintaining the continuum of HIV care well into the adult stage. Toward this aim, our goal is to review key issues in transitioning and maintaining YLHIV in HIV care, highlight steps in the transition process, examine evidence when available, and discuss particular challenges and potential opportunities to understanding and optimizing outcomes for YLHIV.
Epidemiology of YLHIV
Worldwide, there are 1.8 billion adolescents and young adults between the ages of 10 and 24, with 90 % living in RLS, primarily in South America, sub-Saharan Africa, and Asia [1, 9] . Of those, there are approximately 5 million YLHIV between the ages of 10 and 24 (3.9 million 15-24 years old; 1.1 million 10-14 years old). Another estimated 2.1 million children under age 10 are also living with HIV infection [10, 11] , with about 200,000 newly diagnosed children each year [1, 12, 13] . Not a monolithic group, YLHIV globally include those who have acquired infection perinatally, aging into adolescence and adulthood, and non-perinatally, the latter through primarily unprotected sexual intercourse and injection drug use, with a minority infected through blood transfusion and other means. Prevention of mother to child transmission (PMTCT) programs, earlier diagnosis, and ART initiation have reduced childhood infections and improved the survival of children living with HIV infection. However, despite efforts to provide access to all who need it, in 2014, 54 % of pregnant women in low-and middle-income countries received an HIV test, 66 % of known HIV-infected pregnant women receive PMTCT, and 48 % of children of women diagnosed with HIV undergo appropriate diagnostic testing to assess infection status [10, 14] . Significant numbers of these children are diagnosed in late childhood or adolescence when they present with complications of progressive immune deterioration or when identified by testing algorithms developed to capture those that may have eluded diagnosis at a younger age [15] . Further, individuals between the ages of 15 and 24 account for an estimated 34 % [12] of incident HIV infections, with risk factors varying by region (young girls in Sub-Saharan Africa, men who have sex with men in North and South America, commercial sex workers in Asia, and people who inject drugs in Eastern Europe) [16] . As the numbers of HIVinfected adolescents and young adults increase, challenges in their care and management are being recognized [4] .
Psychosocial and Medical Challenges of YLHIV

Psychosocial Challenges
Cognitive, developmental, psychosocial, health infrastructure-related, and environmental challenges impact YLHIV's capacity to engage and remain in care (Table 1) . Complexities inherent during the cognitive and development phase of adolescence may trigger age-appropriate defiance of oversight and autonomy seeking, but may also lead to opposition against authority, experimentation, a limited capacity to perceive risk, and a sense of invincibility. Youth are also traversing significant evolutionary stages of multi-level physical, psychosocial, and environmental change and development [4] . In addition, the interplay between culture, psychological, and mental development may add a layer of complexity for YLHIV and their healthcare providers.
Medical Challenges: Adherence, Morbidity, and Disparate Outcomes Several of the developmental issues encountered by YLHIV, while often normal and age-appropriate, can result in nonadherence to medical care, management, and medications, with resultant virologic failure. Indeed, up to 72 % of YLHIV experience virologic failure [17, 18] . ART-resistant HIV can also be of significant consequence, particularly in settings where access to second-and third-line ART regimens is limited [4] . Co-morbidities (infectious and non-infectious, HIV and non-HIV related) increase the complexity of medication adherence and how YLHIV need to engage in the medical system [4, 19] . These challenges are being associated with the potential for increased mortality risk. For example, between period 2005 and 2012, AIDS-related deaths among adolescents increased by about 50 % (from 71,000 in 2005 to 110,000 in 2012), in contrast with a 32 % decrease among all other age groups during the same period [20] . AIDSrelated conditions are now the leading cause of death among adolescents (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) in Africa and the second leading cause of death among adolescents globally [13] . This increase may be attributed to decreased access to youth friendly, appropriate HIV care including life-saving treatment, as well as nonadherence, limited treatment options, and other challenges of care and management of YLHIV [4, 14] . Aggregated YLHIV data included with older adults (i.e., 15-29 or 18-40) diminishes the capacity to truly assess outcomes for YLHIV. However, when disaggregated data in the U.S. is evaluated, it is increasingly recognized that YLHIV have the highest rates of attrition and nonadherence to medical care [3, 5, 21, 22, 23•] . Lessons from resource-rich settings that have a large proportion of their YLHIVapproaching adulthood reveal significant challenges with attrition in this population. In the US-based HIV Research Network (HIVRN) cohort, only 44 % of non-perinatally acquired YLHIV were still engaged in care 1 year after entry with a staggering 22 % remaining retained in care after 3 years [3] . In examining both perinatal and non-perinatal YLHIV between the ages of 12 and 24, the HIVRN also showed increased likelihood of youth being lost to follow-up (LTFU) with increasing age at enrollment in care [24] . Notably, in the latter study, the authors were unable to comment on transition as robust mechanisms to follow youth beyond the age of transition, which was 25 in most of the included clinics, was limited. There are little outcomes data from RLS. Nglazi et al. [25••] show that adolescents had subs t a n t i a l l y l ow e r r a t e s o f v i r o l o g i c s u pp r e s s i o n (<400 copies/mL) at 48 weeks on combination ART compared to young adults (20-28 years) (27.3 vs. 63.1 %, respectively, p < 0.001), and Evans et al. showed that at 12 months post-ART initiation, 17-30 % of adolescents had experienced virologic failure [17, 18] . In the Evans study, older adolescents and young adults had a higher likelihood of being lost to follow-up after initiating ART (HR 1.78 95 % CI 1.34-2.36; HR 1.63 95 % CI 1.41-1.89) with young adolescents less likely to lost to follow-up (HR 0.43 95 % CI 0.26-0.69) compared to adults [18] .
Clinical Structures of Care for YLHIV
The structures of health care, particularly in RLS, are highly variable and differ according to age, available human resources, and availability of youth-friendly services. Specifically, YLHIV between the ages 10 and 24 may be seen in general care with patients of all ages and are less likely to be seen in environments focused only on pediatric care, adolescent care, or youth-friendly clinical spaces. Youth-friendly spaces are defined by the World Health Organization (WHO) as provision of services that are Accessible, Acceptable, Equitable, Appropriate (including sexual and reproductive health services), Effective, and delivered in a nonjudgmental and confidential manner [26] . There is variability in the clinical space (environment and attitude and perceptions of the staff), issues of disclosure, and clinic size (provider-topatient ratio). The care delivery model may also be different (primary and multidisciplinary care in the same space, integration of primary and HIV care, co-located services, such as sexual reproductive services, alcohol, tobacco, and other substance abuse treatment, and availability of support services). Lastly, there are differences in provider training, the provider-patient relationship, and involvement of family and guardians in the youth's care that may impact care and outcomes. The increasing understanding and appreciation of the unique characteristics of the adolescent stage has led to the establishment of adolescent medicine as a subspecialty and the development of the concept of youth-friendly approaches and clinics to facilitate the engagement of adolescents in multifaceted care. However, there are limited providers with adolescent-specific training, particularly in low-income settings. Specifically, while 90 % of adolescent medicine providers reside in North America, 90 % of youth live in RLS [27] . The capacity to provide age-and developmentally appropriate comprehensive care to YLHIV may be severely limited to non-existent in many RLS. There are real-world challenges to providing youth-friendly primary care in RLS, and the capacity to provide that care to YLHIV may be even more restricted, creating potential gaps in the care and management of HIV within the context of the emerging adolescent/young adult, and as a result potentially enhance the disparities outlined above. As a result, depending on the setting, there may be several transition models (e.g., transition from pediatric to youth-friendly care, transition from pediatric directly to adult care, or care is provided in combined programs where adults and pediatric patients are seen by the same providers without any real distinction of adolescence and no transition occurs). The last model, where the transition is not a physical change but a change in approach to aid YLHIV in gaining more healthcare independence, may actually be the most relevant to RLS.
Transition Defined
Transition is the Bpurposeful and planned movement of children with special health care needs from child-to-adultcentered health care^ [28] . It is considered to be a multifaceted and active process that takes the entire youth into context, addressing the medical, psychosocial, academic, and vocational needs of youth as they traverse from supported healthcare to independent healthcare. The need to transition to independent healthcare is not unique to YLHIV as there are many conditions (e.g., sickle cell disease, cystic fibrosis [29] , type I/II diabetes mellitus [30] [31] [32] , rheumatologic conditions [33] , neurodegenerative disorders) where ultimately youth outgrow the infrastructure of pediatric clinics and must transition to adult care. In fact, many models have tried to optimize transition with variable degrees of success [34] . A recent Cochrane review highlighted the challenges with transition across several chronic disease conditions and underscored the lack of data supporting any interventions to improve transition outcomes [35] . Moreover, the HIV-specific medical challenges, psychosocial milieu, and impact on families and communities make issues related to transition unique and likely more challenging than in most other chronic conditions, particularly in low-income settings.
Children and YLHIV may transition to adult care anywhere between the ages of 8 and ≥15. In fact, in many RLS, transfer may occur even earlier when the child is medically stableclinically well, virally suppressed, and immunologically stable-due to resource constraints in more specialized environments. This transition can set the stage for gaps in care resulting from limited provider experience or knowledge of the unique developmental, psychosocial, and physical attributes of youth. Given the realities of transition in RLS, YLHIV may remain in general HIV care or transfer from pediatric to adult clinics, both settings where there may be limited experience in the care and management of YLHIV and their unique needs. Therefore, mechanisms to bolster their maintenance in care as they transition are desperately needed. Care providers in RLS need to facilitate YLHIV in developing independence regarding maintenance of their HIV care. Closely aligned is the necessity to build capacity to effectively care for YLHIV on both sides of the healthcare setting divide (i.e., pediatric to adult), define successful transition, establish mechanisms to monitor and track, and assess outcomes and factors associated with good outcomes.
What is SUCCESSFUL transition?
There is a critical need to examine the continuum of care posttransition for YLHIV. Figure 1 visualizes this transition continuum, starting with the number of YLHIV eligible for transition to adult services, followed by those who effectively transfer care (seen at least once by an adult provider in the adult clinic), then the proportion who become engaged in care, retained (utilizing regionally appropriate established measures for care and retention, e.g., the U.S. Health Resources and Services Administration (HRSA) measure), and then maintenance or improvement in the level of ART use and adherence and virologic suppression. Further, maintenance of immunologic integrity and disease-free survival would also be important. The outcomes of the transition continuum would need to be assessed longitudinally and maintained (i.e., continued retention and adherence to therapy with virologic suppression), as short-term outcomes are insufficient to truly determine sustainable success. In this particular age group, secondary outcomes including anthropometry (weight, height), WHO HIV clinical staging and CD4 count, sexual and reproductive health outcomes including sexual partnerships, unsafe sex, unplanned pregnancies, contraception uptake and adherence, and episodes of STIs and mental health issues may be important in evaluation comprehensive outcomes.
Challenges of Transition
The medical and psychosocial challenges that impact YLHIV often result in multiple patient, provider, and systemic barriers to transition (Table 2) . Frequently, there is little transition preparation and planning for YLHIV, and linkage between referring and receiving clinics is lacking. The barriers, including poor communication, have consistently emerged as themes in qualitative studies examining challenges/barriers to transition from the perspectives of both YLHIV and their providers [8, 28, 32, 36] . Barriers can align, generating circumstances where YLHIV fail to transition effectively. There is limited data about transition outcomes in RLS, and again, it is important to highlight that the health infrastructure is often significantly different than that of resource-rich settings, making issues of transition unique. Data collection systems are frequently not set up to track transition and outcomes from one clinical environment to another, confounding this problem. Most of the limited available data from the United States, United Kingdom, and Thailand is highlighted in Table 3 . The YLHIV in the studies, given the regions they are from, tend to be older than the likely age of transition in RLS. Reported rates of transition from pediatric to adult care vary from 47 to 92 % [37•, 38•, 39-41] . Ryscavage et al. reported on their transition program utilizing medical and psychosocial support, case management, and peer providers for 50 youth ages 21-25, with 19 perinatally acquired HIV and reported only 50 % retained in care 12 months following transition (defined as two visits in 12 months with one in each 6-month period) [38] . One of the only published studies examining transition outcomes in RLS, a unique cohort-based transition approach of 67 perinatally acquired HIV over the age of 15 in Thailand, reported 73 % remaining in active follow-up 1 to greater than 6 years after transition [37] . Others, including our own respective transition clinics, the Accessing Care Early (ACE) clinic at Johns Hopkins (Agwu, Griffith) and Jackson Fund Martin Clinics at Mt. Sinai (Jao), report transition rates of 72 and 77 %, respectively, 12 months after transfer from the pediatric/adolescent clinics. The compiled data in Table 3 reflect the significant variability in definitions of successful transition across the studies to date, which makes comparison of interventions and assessment of outcomes across studies challenging.
Current Limitations in Studying Transitions for YLHIV
With recognition of the potential challenges, there is mounting interest in quantifying barriers to successful transition, assessing factors associated with transition outcomes, such as readiness to transition, and determining interventions that may improve those outcomes [42, 43] . There are currently many limitations to examining transitions (Table 2 ) [44] . First and foremost, inconsistent definitions of critical terms, e.g., successful transition, adolescent, and youth, and incomplete and inconsistent data collection limit the ability to examine utilization data to analyze transition. These challenges exist worldwide, but are particularly highlighted in RLS. With increasing utilization of electronic medical records across clinics, institutions, and regionally, some of the challenges may be overcome. Additionally, various initiatives (e.g., Pediatric HIV/AIDS Cohort Study (PHACS) Collaborative Initiative for Paediatric HIV Education and Research (CIPHER)) and funding agencies are attempting to coordinate and harmonize data between and across cohorts to begin to tackle the questions about transition in various settings, including RLS. Over the ensuing years, we hope to see published quality reports of baseline transition outcomes as well as potential results of emerging interventions [44] .
Potential Interventions That Can Improve Transitions and Impact Longitudinal Outcomes for YLHIV
Current adherence interventions take the form of alternate models of care (e.g., adherence and youth clubs), service integration, targeted focused structures/specialty clinics, support groups, and peer navigators, among others [45] . A recent review by Judd et al. examined interventions to improve adherence outcomes for youth living with perinatally acquired HIV infection transitioning to adult care and found no studies specifically examining interventions for YLHIV from pediatric to adult clinical services, with most studies examining adherence among YLHIV prior to the transition in middle-and high-income countries, with none in RLS [46••] . Looking to lessons from outside the HIV experience, the authors of a Cochrane review of interventions to improve transitions in chronic non-HIV conditions examined a variety of interventions (e.g., workshops, SMS-based educations interventions, structured transition programs) with a variety of outcomes (e.g., readiness to transition, use of health services, disease outcomes) and found that there were few randomized control studies, a variety of outcomes, and short longitudinal follow-up. While these were reported to show some promising evidence for improvements in patient knowledge, no clear and consistent impact on outcomes of transition (e.g., higher rates of follow-up, treatment adherence, and quality disease management) was demonstrated [35, 47] . Given the current landscape of challenges and negative outcomes being seen for YLHIV, focusing on transitions may be critical to turning the tide and optimizing outcomes. Handbooks and toolkits as well as training programs focused on the delivery of youth-friendly services may improve care for YLHIV in RLS [48] .
To underscore the importance of certain aspects of HIV care, standardized quality of care indicators are increasingly being utilized to evaluate HIV care outcomes and to improve standards by providing a score card for programs. Specifically, benchmarks along the cascade from ART initiation to VL suppression are being used in devising these scores. In RLS, standardization may be more challenging, given varying funders and varying capacity to obtain laboratory data, inconsistent implementation of medical data collection systems, etc. However, attempts are being made to improve this at the country level. No such standards exist for transition, and programs have little incentive for improving transition and its outcomes. Adding transition to quality improvement standards may be one mechanism to highlight its importance and therefore compel programs to strengthen this process. While evolving research is attempting to determine best practices for transitions, YLHIV continue to approach the age of transition and guidelines have been developed to assist providers and programs with transitioning YLHIV [28] . While mostly based on consensus opinion, the guidelines do provide practical recommendations for programs to address YLHIV through the period of transition. Given the potential differences between the clinical settings and infrastructure across resource-rich and RLS, the recommendations do need to be adapted to the specific context of the RLS. However, certain issues, such as the need for documentation, communication, clarity, education, tracking, and involving the YLHIV and preferably the caregivers in the transition process, to name a few, likely transcend clinical setting [49] . Programs should evaluate and publish their experiences, both positive and negative, to inform the greater community on how to enhance the continuum of care, particularly during the period of transition, for YLHIV.
Questions Remaining Surrounding Successful Transition
In order to specifically examine and ultimately optimize transitions, several questions must be asked, including the following: With such questions, there is ample opportunity and need for research, including implementation science approaches to providing answers. Recognition that YLHIV are not a homogenous group is important as there are likely a multitude of approaches that may be successful and may vary depending on the individual and context.
Conclusion
Worldwide an unprecedented number of YLHIV, a majority residing in RLS, are approaching adolescence and young adulthood and needing to transition to healthcare independence as an adult. With variability in healthcare delivery and infrastructure, the transition is often not a physical one in RLS. However, in addition to the medical and psychosocial challenges, increasingly evident poorer outcomes with nonadherence and attrition raise concern that a poor transition will exacerbate the emerging disparities in outcomes. Lessons being learned from resourcerich settings regarding transition may provide some insights to how transition can be assessed and potentially managed in RLS. Nonetheless, contextual differences likely demand that RLS will need to determine what practices and interventions may be most effective in their individual settings. Given the magnitude of the HIV epidemic, it is likely that how we approach the transition of YLHIV and the systems that are developed to support them as they navigate from more heavily supported healthcare environments to healthcare independence as an adult will impact long-term healthcare outcomes of YLHIV as well as youth with other chronic conditions.
